Revisión en profundidad | 25 JUN 24

Intervenciones no farmacológicas para el TDAH pediátrico

Eficacia y seguridad de los tratamientos no farmacológicos para el TDAH pediátrico
Autor/a: argaret H Sibley, Alisha M Bruton, Xin Zhao, Jeanette M Johnstone, John Mitchell, Irene Hatsu, L Eugene Arnold, Hana H Basu y otros Lancet Child Adolesc Health 2023
INDICE:  1. Texto principal | 2. Referencia bibliográfica
Referencia bibliográfica

1 Diagnostic and statistical manual of mental disorders: DSM-5, 5th edn. Washington, DC: American Psychiatric Publishing, 2013.

2 Hechtman L, Swanson JM, Sibley MH, et al. Functional adult outcomes 16 years after childhood diagnosis of attention-deficit/hyperactivity disorder: MTA results. J Am Acad Child Adolesc Psychiatry 2016; 55: 945–52.

3 Altszuler AR, Page TF, Gnagy EM, et al. Financial dependence of young adults with childhood ADHD. J Abnorm Child Psychol 2016; 44: 1217–29.

4 Bagwell CL, Molina BS, Pelham WE Jr, Hoza B. Attention-deficit hyperactivity disorder and problems in peer relations: predictions from childhood to adolescence. J Am Acad Child Adolesc Psychiatry 2001; 40: 1285–92.

5 Kuriyan AB, Pelham WE Jr, Molina BSG, et al. Young adult educational and vocational outcomes of children diagnosed with ADHD. J Abnorm Child Psychol 2013; 41: 27–41.

6 Barkley RA, Fischer M. Hyperactive child syndrome and estimated life expectancy at young adult follow-up: the role of ADHD persistence and other potential predictors. J Atten Disord 2019; 23: 907–23.

7 Babinski DE, Mazzant JR, Merrill BM, et al. Lifetime caregiver strain among mothers of adolescents and young adults with attention-deficit/hyperactivity disorder. J Fam Psychol 2020; 34: 342–52.

8 Hodgkins P, Montejano L, Sasané R, Huse D. Cost of illness and comorbidities in adults diagnosed with attention-deficit/ hyperactivity disorder: a retrospective analysis. Prim Care Companion CNS Disord 2011; 13: PCC.10m01030.

9 Rösler M, Retz W, Retz-Junginger P, et al. Prevalence of attention deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates. Eur Arch Psychiatry Clin Neurosci 2004; 254: 365–71.

10 Fletcher JM. The effects of childhood ADHD on adult labor market outcomes. Health Econ 2014; 23: 159–81.

11 Swanson JM, Arnold LE, Molina BSG, et al. Young adult outcomes in the follow-up of the multimodal treatment study of attentiondeficit/hyperactivity disorder: symptom persistence, source

discrepancy, and height suppression. J Child Psychol Psychiatry 2017; 58: 663–78.

12 Swanson JM, Kinsbourne M, Nigg J, et al. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis.

Neuropsychol Rev 2007; 17: 39–59

13 Thapar A. Discoveries on the genetics of ADHD in the 21st century: new findings and their implications. Am J Psychiatry 2018; 175: 943–50.

14 Faraone SV, Bonvicini C, Scassellati C. Biomarkers in the diagnosis of ADHD—promising directions. Curr Psychiatry Rep 2014; 16: 497.

15 Anand D, Colpo GD, Zeni G, Zeni CP, Teixeira AL. Attentiondeficit/hyperactivity disorder and inflammation: what does current knowledge tell us? A systematic review. Front Psychiatry 2017; 8: 228.

16 Verlaet AA, Noriega DB, Hermans N, Savelkoul HFJ. Nutrition, immunological mechanisms and dietary immunomodulation in ADHD. Eur Child Adolesc Psychiatry 2014; 23: 519–29.

17 Wang LJ, Yang CY, Chou WJ, et al. Gut microbiota and dietary patterns in children with attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry 2020; 29: 287–97.

18 Bozinovic K, McLamb F, O’Connell K, et al. US national, regional, and state-specific socioeconomic factors correlate with child and adolescent ADHD diagnoses pre-COVID-19 pandemic. Sci Rep 2021; 11: 22008.

19 Haack LM, Villodas MT, McBurnett K, Hinshaw S, Pfiffner LJ. Parenting mediates symptoms and impairment in children with ADHD-inattentive type. J Clin Child Adolesc Psychol 2016; 45: 155–66.

20 Goodlad JK, Marcus DK, Fulton JJ. Lead and attention-deficit/hyperactivity disorder (ADHD) symptoms: a meta-analysis. Clin Psychol Rev 2013; 33: 417–25.

21 Morsink S, Sonuga-Barke E, Mies G, et al. What motivates individuals with ADHD? A qualitative analysis from the adolescent’s point of view. Eur Child Adolesc Psychiatry 2017; 26: 923–32.

22 Bradley C. The behavior of children receiving nattentiv. Am J Psychiatry 1937; 94: 577–85.

23 Caye A, Swanson JM, Coghill D, Rohde LA. Treatment strategies for ADHD: an evidence-based guide to select optimal treatment. Mol Psychiatry 2019; 24: 390–408.

24 Brinkman WB, Simon JO, Epstein JN. Reasons why children and adolescents with attention-deficit/hyperactivity disorder stop and restart taking medicine. Acad Pediatr 2018; 18: 273–80.

25 Toomey SL, Sox CM, Rusinak D, Finkelstein JA. Why do children with ADHD discontinue their medication? Clin Pediatr (Phila) 2012; 51: 763–69.

26 Schatz NK, Fabiano GA, Cunningham CE, et al. Systematic review of patients’ and parents’ preferences for ADHD treatment options and processes of care. Patient 2015; 8: 483–97.

27 Berkman ND, Lohr KN, Ansari MT, et al. Grading the strength of a body of evidence when assessing health care interventions: an EPC update. J Clin Epidemiol 2015; 68: 1312–24.

28 Conners CK, Epstein JN, March JS, et al. Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. J Am Acad Child Adolesc Psychiatry 2001; 40: 159–67.

29 Jensen PS, Garcia JA, Glied S, et al. Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. Am J Psychiatry 2005; 162: 1628–36.

30 Coghill D, Banaschewski T, Cortese S, et al. The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG). Eur Child Adolesc Psychiatry 2021; 2021: 1–25.

31 Kamradt JM, Ullsperger JM, Nikolas MA. Executive function assessment and adult attention-deficit/hyperactivity disorder: tasks versus ratings on the Barkley deficits in executive functioning scale. Psychol Assess 2014; 26: 1095–105.

32 Clark DL, Arnold LE, Crowl L, et al. Vestibular stimulation for ADHD: randomized controlled trial of Comprehensive Motion Apparatus. J Atten Disord 2008; 11: 599–611.

33 Arnold LE, Lofthouse N, Hersch S, et al. EEG neurofeedback for ADHD: double-blind sham-controlled randomized pilot feasibility trial. J Atten Disord 2013; 17: 410–19.

34 Schünemann H. The GRADE handbook. 2013. https://gdt.gradepro.org/app/handbook/ handbook.html (accessed June 3, 2022).

35 Sonuga-Barke EJ, Brandeis D, Cortese S, et al. Non pharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024